18 Aug

RADIO NEW ZEALAND NATIONAL_Valneva New Study

Exciting for PharmaSols CRO and NZ to be involved in this international COVID-19 vaccine trial. “New Zealand needs to continue to contribute to the global effort to develop Covid-19 vaccines. This study gives New Zealanders an opportunity to be involved at a personal level. The participation of older adults is critical to help evaluate new vaccines for this population." Dr Frances Priddy

https://lnkd.in/ghDhVkba

Other News

Australia and New Zealand – the haven for Patient Recruitment and Retention in Clinical Trials

Patient recruitment and retention are critical for the success of any clinical trial. It is widely accepted that almost half of all delays in clinical trials are a result of problems with patient recruitment and retention.

Read more
Quality, Speed and Cost – Where can clinical trials deliver all three?

Australia and New Zealand are considered as the go-to place to conduct clinical trials for an increasing number of global sponsors. That’s not surprising as the region generates high quality clinical data while being time- and cost-effective.

Read more
How biotechs are using streamlined Ethics and Regulatory processes in ANZ to accelerate clinical trials

We’ve always heard about the saying, time is money. You might wonder how this applies to clinical trials.

Read more